IFOSFAMIDE
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | IFOSFAMIDE |
| DrugBank ID | DB01181 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 29 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| neuroblastoma | TxGNN Knowledge Graph | L5 |
| mycosis fungoides and variants | TxGNN Knowledge Graph | L5 |
| retinal neuroblastoma | TxGNN Knowledge Graph | L5 |
| lymphoma | TxGNN Knowledge Graph | L5 |
| breast carcinoma | TxGNN Knowledge Graph | L5 |
| primary cutaneous t-cell lymphoma | TxGNN Knowledge Graph | L5 |
| folliculotropic mycosis fungoides | TxGNN Knowledge Graph | L5 |
| retinoblastoma | TxGNN Knowledge Graph | L5 |
| granulomatous slack skin disease | TxGNN Knowledge Graph | L5 |
| plasma cell myeloma | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11